A
$ Value
$21K
Shares
890
Price
$24
Filed
Jul 2
Insider
Name
Cheng Andrew
Title
President and CEO
CIK
0001778307
Roles
Director
Officer
Transaction Details
Transaction Date
2025-06-30
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
550,757
Footnotes
Dr. Cheng is voluntarily reporting the acquisition of these shares on June 30, 2025 pursuant to the Akero Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(c) and Rule 16b-3(d). | In accordance with the provisions of the Akero Therapeutics, Inc. 2019 Employee Stock Purchase Plan, these shares were purchased at 85% of the closing price of the Issuer's common stock on January 2, 2025.
Filing Info
Cheng Andrew's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-09 | AKRO | D | — |
| 2025-12-09 | AKRO | D | — |
| 2025-12-09 | AKRO | D | — |
| 2025-12-09 | AKRO | D | — |
| 2025-12-09 | AKRO | D | — |
| 2025-12-09 | AKRO | D | — |
| 2025-12-09 | AKRO | D | — |
| 2025-12-09 | AKRO | D | — |
| 2025-12-09 | AKRO | D | — |
| 2025-12-09 | AKRO | D | — |
Other Insiders at AKRO (90d)
No other insider activity at this issuer in the last 90 days.